VRDN
Viridian Therapeutics
$19.70
+$0.43 (+2.23%)Jul 27, 2026
Key metrics
The numbers that frame VRDN today
- Market cap
- $2.03B
- P/E (TTM)
- -5.6
- EV / FCF
- -6.4
- Gross margin
- 100%
- EV / Sales
- 27.4
- ROIC
- -65.4%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $13.19
- 52wk High
- $34.29
Growth
Revenue and earnings trend for VRDN
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about VRDN
Is Viridian Therapeutics a good buy?
No. Viridian Therapeutics has poor quality and weak momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Viridian Therapeutics is selling at a very high price.
What is the market capitalization of VRDN?
Viridian Therapeutics's market capitalization is $2.03B.
What is the P/E ratio for VRDN stock?
Viridian Therapeutics's current P/E ratio is -5.6.
What is the 52-week high for VRDN stock?
The 52-week high for Viridian Therapeutics is $34.29. The current close of $19.70 is 42.5% below that high.
What is the 52-week low for VRDN stock?
The 52-week low for Viridian Therapeutics is $13.19. The current close of $19.70 is 49.4% above that low.
Does VRDN stock pay dividends?
Viridian Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for VRDN?
Viridian Therapeutics's Debt / Equity ratio is 0.14.